Depression is a common problem among older adults, affecting 15-27% of community-dwelling older people and up to 37% of those in primary care. Untreated depression can negatively impact physical health and recovery. Diagnosis involves assessing symptoms like depressed mood, loss of interest, changes in appetite, and fatigue. Effective treatment includes both pharmacological options like SSRIs and non-pharmacological therapies such as cognitive behavioral therapy. Regular screening is important to identify depression early in older patients.
This presentation is about geriatric Psychiatry awareness. it contains basic information about what is geriatric psychiatry, which are the main psychiatry disorder found in elderly and how to manage them?. it contains some detailed information about late life depression, delirium and dementia in geriatric population.
Depression is more than just feeling sad or blue. It is a common but serious mood disorder that needs treatment. It causes severe symptoms that affect how you feel, think, and handle daily activities, such as sleeping, eating, and working.
Mental health issues such as depression and anxiety are NOT a normal part of aging and are hard to discuss, diagnose and treat. The good news is that there are innovative programs, tools and resources that can help.
This presentation is about geriatric Psychiatry awareness. it contains basic information about what is geriatric psychiatry, which are the main psychiatry disorder found in elderly and how to manage them?. it contains some detailed information about late life depression, delirium and dementia in geriatric population.
Depression is more than just feeling sad or blue. It is a common but serious mood disorder that needs treatment. It causes severe symptoms that affect how you feel, think, and handle daily activities, such as sleeping, eating, and working.
Mental health issues such as depression and anxiety are NOT a normal part of aging and are hard to discuss, diagnose and treat. The good news is that there are innovative programs, tools and resources that can help.
Depression in elderly people, also known as late-life depression, is a clinical syndrome characterized by persistent feelings of sadness, loss of interest or pleasure in activities, and a range of emotional, cognitive, and physical symptoms that significantly impact the individual's functioning and quality of life.
Generalized Anxiety Disorder- What It Is And How To Treat ItCarlo Carandang
Comprehensive review of generalized anxiety disorder (GAD), by Dr. Carlo Carandang, MD, anxiety expert and psychiatrist. Brought to you by AnxietyBoss.com.
Aging is associated with cognitive decline, and older subjects can have demonstrable cognitive impairment without crossing the threshold for dementia.
This condition has been termed “mild cognitive impairment” (MCI), and these patients have an increased risk of developing dementia, especially Alzheimer disease (AD).
Studies conducted in referral clinics have shown that patients with MCI progress to AD at a rate of 10% to 15% per year, and 80% of these patients have converted to AD after approximately 6 years of follow-up.
The identification and classification of MCI can be a major challenge.
Depression in elderly people, also known as late-life depression, is a clinical syndrome characterized by persistent feelings of sadness, loss of interest or pleasure in activities, and a range of emotional, cognitive, and physical symptoms that significantly impact the individual's functioning and quality of life.
Generalized Anxiety Disorder- What It Is And How To Treat ItCarlo Carandang
Comprehensive review of generalized anxiety disorder (GAD), by Dr. Carlo Carandang, MD, anxiety expert and psychiatrist. Brought to you by AnxietyBoss.com.
Aging is associated with cognitive decline, and older subjects can have demonstrable cognitive impairment without crossing the threshold for dementia.
This condition has been termed “mild cognitive impairment” (MCI), and these patients have an increased risk of developing dementia, especially Alzheimer disease (AD).
Studies conducted in referral clinics have shown that patients with MCI progress to AD at a rate of 10% to 15% per year, and 80% of these patients have converted to AD after approximately 6 years of follow-up.
The identification and classification of MCI can be a major challenge.
Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest. Also called major depressive disorder or clinical depression, it affects how you feel, think and behave and can lead to a variety of emotional and physical problems.
Depression is a common mental illness that can have a significant impact on an individual's quality of life. It is critical to perceive the signs and side effects of misery and look for proficient assistance if necessary. With the right treatment and support, individuals with depression can manage their symptoms and improve their overall well-being.
Major depressive disorder, also known as depression, is a severe medical condition that affects people's feelings, thoughts, and behaviours.Read more:https://mpmacolorado.blogspot.com/2023/03/all-about-depression.html
SUICIDE:
is the result of an act of self harm
deliberately initiated and
performed in the full knowledge or expectation of its Fatal Outcome.
Suicidal acts with nonfatal outcome are labeled by WHO as "Attempted Suicide”.
Derived from Latin word ,sui = oneself , cidium = a killing
Primary emergency for mental health professional
Major public health problem
More than 8,00,000 people die by suicide every year
Estimated annual mortality is 14·5 deaths per
1,00,000 people
Around one person every 40 seconds
75% of suicides occur in low- and middle-income countries
Tenth leading cause of death worldwide
It is the second leading cause of death in 15-29 year olds globally
suicide belt – (25 per 100,000) Scandinavia, Switzerland, Germany, Austria, eastern European countries (Belarus, Estonia, Lithuania, and the Russian Federation) and Japan
Prime suicide site of the world – Golden Gate Bridge in San Francisco
Japan- reported to have highest number of cases
Every year, more than 1,00,000 people commit suicide in our country. There are various causes of suicides like professional/career problems, sense of isolation, abuse, violence, family problems, mental disorders, addiction to alcohol, financial loss, chronic pain etc
According to NCRB:
A total of 1,39,123 suicides were reported in the country during 2019 showing an increase of 3.4% in comparison to 2018 and the rate of suicides has increased by 0.2% Scerotonergic system: low concentration of HIAA (metabolite of serotonin)
Non adrenergic system: stress-diathesis model
HPA axis: Dexamethasone suppression test- non-suppressors
Genetic:
Molecular biology – polymorphism in TPH gene
(tryptophan hydroxylase enzyme)
2019 over 2018.
Gender differences- Men 4 times > Women Exceptions – India and China , ratio is 1.3:1
Age- Increase with age
men peak age- after 45 years women – 55years
Physical health- loss of motility, Disfigurement, chronic intractable pain , patients on hemodialysis alcohol related illnesses
Mental illness
Previous h/o suicidal attempt
H/O Substance abuse
Marital status
Social isolation
Trouble coping with recent losses, death, divorce, moving, break-ups, etc.
Feelings of hopelessness and despair
Making final arrangements: writing a will or eulogy, or taking care of details (i.e. closing a bank account).
Gathering of lethal weapons
Giving away prized possessions
Preoccupation with death, such as death and/or 'dark' themes in writing, art, music lyrics, etc.
Sudden changes in personality or attitude, appearance, chemical use, or school behavior.Problem-solving
b) Psychotherapy
c) Distress-tolerance skills
d) Outreach
e) Provision of emergency cards
f)Antidepressants- fluoxetine, should be always combined with other therapies
b) Neuroleptics- flupenthixol 20mg for 6 months
c) Lithium
Family therapy
In the 1980, to reduce the heterogeneity of schizophrenia, researchers tried to identify homogeneous subtypes in the hope to facilitate the identification of links between symptoms and The division of symptoms as positive or negative and categorization of schizophrenia as positive and negative subtypes became popular. However, researchers noticed that negative symptoms were not inherent to the disorder alone, but may also be due to neuroleptic medications, depression and environmental factors. This was shared by the concept of primary and secondary negative symptoms. To better understand primary negative symptoms, a separate subtype of schizophrenia, deficit and non-deficit schizophrenia was given by Carpenter.According to Carpenter et al. the term ‘deficit symptoms’ should be used to refer specifically to those negative symptoms that are present as enduring traits.
These deficit symptoms occur regardless of the patient's medication status and are not specifically responsive to anticholinergic drugs or antipsychotic drug withdrawal. It was further conceptualized that the presence of poor premorbid adjustment preceding initial psychotic episode may be manifestations of the deficit syndrome. In 2001, a review of the literature suggested that deficit schizophrenia is a disease separate from other, nondeficit forms of schizophrenia .
The proposal of a separate disease was based on the evidence that deficit and nondeficit schizophrenia differ on five dimensions typically used to distinguish diseases: signs and symptoms, course of illness, pathophysiological correlates, risk and etiological factors, and treatment response.Family history
Kirkpatrick et al reviewed studies showing that the deficit/nondeficit categorization has a significant concordance within families and that family members of deficit probands, compared with relatives of nondeficit probands, have more severe social withdrawal and an increased risk of schizophrenia.
Genetics
A few studies have examined the genetics of deficit and nondeficit schizophrenia, but the results have been disappointing.
Hong et al (6) reported that the dihydropyrimidinase-related protein 2 (DRP-2) gene was associated with risk for both deficit and nondeficit schizophrenia; however, after correcting for multiple comparisons, the association with nondeficit schizophrenia was not significant, and for deficit schizophrenia the association was present only for Caucasian but not African-American Deficit patients have a more severe course of illness than nondeficit patients, with a higher prevalence of abnormal involuntary movements before administration of antipsychotic drugs and poorer social function before the onset of psychotic symptoms.
The prevalence of deficit schizophrenia has been reported to be about 15% among patients with first-episode schizophrenia and 25%–30% among those with chronic schizophrenia
The risk factor of deficit patients differ from those of nondeficit patients. Deficit patients may a
Schizophrenia A chronic mental disorder involving a breakdown in the relation between thought, emotion, and behaviour, leading to faulty perception, inappropriate actions and feelings, withdrawal from reality and personal relationships into fantasy and delusion, and a sense of mental fragmentation.
Antipsychotic Agents Antipsychotic drugs are able to reduce psychotic symptoms in a wide variety of conditions, including schizophrenia, bipolar disorder, psychotic depression and drug induced psychosis. They have also been termed neuroleptics, because they suppress motor activity and emotionalityClinical Efficacy of Antipsychotic Drugs
Antipsychotic drugs are effective in controlling symptoms of acute schizophrenia, when large doses may be needed.
Long-term antipsychotic treatment is often effective in preventing recurrence of schizophrenic attacks, and is a major factor in allowing schizophrenic patients to lead normal lives.
Classification of Antipsychotic Drugs Typical antipsychotics Phenothiazines (Chlorpromazine, Perphenazine, Fluphenazine, Thioridazine) Thioxanthenes (Flupenthixol, Clopenthixol) Butyrophenones (Haloperidol, Droperidol)
Atypical antipsychotics (Clozapine, Risperidone, Sulpiride, Olanzapine, Aripiprazole)
Depot preparations are often used for maintenance therapy.
Approximately 40% of chronic schizophrenic patients are poorly controlled by antipsychotic drugs; clozapine may be effective in some of these ‘antipsychotic-resistant’ cases.
The dramatic outburst of Coronavirus disease (COVID-19) on the global stage has amazed many people and left us feeling vulnerable and helpless.The widespread outbreak of COVID-19 virus has brought not only the risk of death but also major psychological pressure
Understandably, there has been much emphasis on the effect of the pandemic on the health of the population, as well as the consequences of the potential loss of life from overwhelmed public health systems.
Mental retardation{intellectual disability} is a condition of arrested or incomplete development of mind, which is specially characterized by impairment of skills manifested during the developmental period, which contribute to the overall level of intelligence, i.e cognitive, language, motor and social abilities.
Prevalence of mental disorders is 4-5 times higher in person with intellectual disability
CAUSES-
GENETIC
ENVIORNMENTAL/SOCIO-CULTURAL
PRENATAL,PERINATAL AND POSTNATAL FACTOR
COMBINED Behavior management
Monitoring the child’s development needs & problems.
Programs that maximize speech, language, cognitive, psychomotor, social, self-care, & occupational skills.
Ongoing evaluation for overlapping psychiatric disorders, such as depression, bipolar disorder, & ADHD.
Family therapy to help parents develop coping skills & deal with guilt or anger.
Provide day schools to train the child in basic skills, such as bathing & feeding.
“Mindfulness" originates from the Pali term sati and in its Sanskrit counterpart smṛti.
Sati/ Smṛti originally meant "to remember" , "to recollect" , "to bear in mind“Formal mindfulness, most often referred to as meditation, involves intense introspection whereby one sustains one’s attention on an object (breath, body sensations) or on whatever arises in each moment (called choice less awareness).
Informal mindfulness is the application of mindful attention in everyday life. Mindful eating and mindful walking are examples of informal mindfulness practices. In fact any daily activity can be the object of informal mindfulness practice.
Non-meditation-based mindfulness exercises are specifically used in dialectical behavior therapy (DBT; Linehan, 1993) and acceptance and commitment therapy (ACT; Hayes, Strosahl, & Wilson, 1999).
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
2. INTRODUCTION
• Depression is under-recognized and
undertreated in the older people.
• 15% - 27% older adults in community & up to
37% in primary care setting experience
depressive symptoms.
• Untreated depression can delay recovery or
worsen the outcome of other medical illnesses
via increased morbidity or mortality
• Depression is NOT a part of normal aging
3. WHAT IS DEPRESSION?
DSM-5 Definition
Five or more of the following must have
been present during the same 2-week
interval and represent a change from
baseline functioning
One of the symptoms must be depressed
mood or loss of interest or pleasure
4. Depressed mood
Loss of interest in all or almost all
activities or pleasure
Appetite change or weight loss
Insomnia or hypersomnia
Psychomotor agitation or
retardation
5. Loss of energy or fatigue
Feelings of worthlessness or excessive
guilt
Difficulty with thinking, concentration, or
decision making
Recurrent thoughts of death or suicide
Preoccupation with somatic symptoms,
health status, or physical limitations
6. For Major Depression, these
symptoms
Produce social impairment
Are not related to substance
abuse
Are not related to bereavement
[the loss of a loved one by death]
7. Types of Depressive Disorders
Mild episode of major depression
Moderate episode of major depression
Severe episode of major depression
Severe episode of major depression with
psychotic features
8. Minor depression is common
15% of older persons
Causes ↑ use of health services, excess disability, poor
health outcomes, including ↑ mortality
Major depression is not common
1%–2% of physically healthy community dwellers
Elders less likely to recognize or endorse depressed mood
9. RISK FACTORS
Alcohol or substance abuse
Current use of a medication associated with a high risk of
depression
Hearing or vision impairment severe enough to affect
function
History of attempted suicide
History of psychiatric hospitalization
Female gender
Bereavement
10. COGNITIVE DEFICITS IN
GERIATRIC DEPRESSION
Cognitive symptoms of severe depression can be misdiagnosed as
an early stage dementing disorder.
The neuropsychological impairment seen frequently in geriatric
depression span across multiple cognitive domains. These include
impairments in episodic memory, recognition memory,verbal
fluency ,psychomotor speed.
The specific structural abnormalities that contribute to symptoms
of depression have been identified in the orbitofrontal cortex, ant
cingulate,putamen, caudate head, hippocampus, amygdala
11. CAUSES
As you grow older, you face significant life changes that
can put you at risk for depression.
Health problems – Illness and disability; chronic or severe
pain; cognitive decline; damage to body image due to
disease.
Loneliness and isolation – Living alone; a dwindling social
circle due to deaths or relocation;
Reduced sense of purpose – Feelings of purposelessness
or loss of identity due to retirement or physical limitations
on activities.
Fears – Fear of death or dying; anxiety over financial
problems or health issues.
Recent bereavement – The death of friends, family
members, and pets; the loss of a spouse or partner.
15. Most commonly used and
validated screening tool for
diagnosis of Depression in the
geriatrics patient:
The Geriatric Depression Scale
16. • It can either be self administered or administered by a
clinician & takes approx. 5-7 minutes to complete. .
• The presence of 5 or more depression symptoms
responses suggests a positive screen for depression.
• The original instrument consist of 30 questions,although
shorter 15-item and ultrashort 4-item versions have been
developed.
17. Geriatric Depression Scale: Short Form
Choose the best answer for how you have felt over the past week:
1. Are you basically satisfied with your life? YES / NO
2. Have you dropped many of your activities and interests? YES / NO
3. Do you feel that your life is empty? YES / NO
4. Do you often get bored? YES / NO
5. Are you in good spirits most of the time? YES / NO
6. Are you afraid that something bad is going to happen to you? YES / NO
7. Do you feel happy most of the time? YES / NO
8. Do you often feel helpless? YES / NO
9. Do you prefer to stay at home, rather than going out and doing new things? YES / NO
10. Do you feel you have more problems with memory than most? YES / NO
11. Do you think it is wonderful to be alive now? YES / NO
12. Do you feel pretty worthless the way you are now? YES / NO
13. Do you feel full of energy? YES / NO
14. Do you feel that your situation is hopeless? YES / NO
15. Do you think that most people are better off than you are? YES / NO
Answers in bold indicate depression. Score 1 point for each bolded answer.
A score > 5 points is suggestive of depression.
18. TREATMENT
Effective management requires a biopsychosocial
approach, combining pharmacotherapy and
psychotherapy.
Therapy generally results in improved quality of life,
enhanced functional capacity, possible
improvement in medical health status, and lower
health care costs.
19. NON
PHARMACOLOGICAL T/T
1. CBT:
teaches individuals to identify maladaptive or distorted cognition &
learn to challenge them
Increasing pleasurable activities and use techniques, such as
activity monitoring & scheduling.
2. IPT:
focus on current relationship in 1 or more of problematic area of life:
grief, interpersonal conflicts, interpersonal deficits.
2. Life review intervention:
focus on evaluating positive & negative events with the goal of
reframing & integrating these events by changing overview of
themselves & the events of their life.
22. PHARMACOTHERAPY
ANTIDEPRESSANTS SHOULD BE CONSIDERED IN PATIENTS WITH
MOD TO SEVERE DEPRESSION & IN PATIENT WITH A MILD TO MOD
DEPRESSION WHO WERE NOT RESPOND WITH NON-
PHARMACOLOGICAL TREATMENT.
Selective Serotonin Reuptake Inhibitors (first line of drug because
of better safety profile)
: fluoxetine
Tricyclic Antidepressants : imipramine and amitriptyline(the use of
TCA has been limited bcz of safety profile, the major safety issue
is their cardiovascular effect)
Monoamine Oxidase Inhibitors
Other Antidepressants: mirtazapine
23.
24. CONSEQUENCES AND
COMPLICATIONS OF
INADEQUATELY TREATED
DEPRESSION
Recurrence, partial recovery, and
chronicity . . .
↑ disability
↑ use of health care resources
↑ morbidity and mortality
Suicide (one fourth of
all suicides occur in
persons ≥ 65)
The illustrated definition of depression is lifted from the DSM-IV-TR (Text Revision) published in 2000 containing updates on diagnostic categories and modified to reflect terminology that is consistent with ICD9 coding.
Mild episode of major depression: minor impairment in social activities, relationships and overall function that persists for at least 2 weeks. Patient does NOT have more than five diagnostic symptoms
Moderate episode of major depression: symptoms or functional impairment between mild and severe, persisting for at least 2 weeks.
Severe episode of major depression: marked interference with and impairment of social activities, relationships, and overall functioning, persisting for at least 2 weeks. Patient has five or more diagnostic symptoms.
Severe episode of major depression with psychotic features: symptoms include delusions and hallucinations